HK1199064A1 - Promoter derived from human gene - Google Patents

Promoter derived from human gene

Info

Publication number
HK1199064A1
HK1199064A1 HK14112671.5A HK14112671A HK1199064A1 HK 1199064 A1 HK1199064 A1 HK 1199064A1 HK 14112671 A HK14112671 A HK 14112671A HK 1199064 A1 HK1199064 A1 HK 1199064A1
Authority
HK
Hong Kong
Prior art keywords
human gene
promoter derived
promoter
derived
gene
Prior art date
Application number
HK14112671.5A
Other languages
English (en)
Chinese (zh)
Inventor
Murakami Kenji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1199064A1 publication Critical patent/HK1199064A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK14112671.5A 2011-11-28 2014-12-17 Promoter derived from human gene HK1199064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011258724 2011-11-28
PCT/JP2012/080532 WO2013080934A1 (fr) 2011-11-28 2012-11-27 Promoteur dérivé d'un gène humain

Publications (1)

Publication Number Publication Date
HK1199064A1 true HK1199064A1 (en) 2015-06-19

Family

ID=48535389

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112671.5A HK1199064A1 (en) 2011-11-28 2014-12-17 Promoter derived from human gene

Country Status (16)

Country Link
US (1) US9862969B2 (fr)
EP (1) EP2787080B1 (fr)
JP (1) JP6025745B2 (fr)
KR (1) KR101931404B1 (fr)
CN (1) CN104066839B (fr)
AU (1) AU2012344855C1 (fr)
BR (1) BR112014012682A2 (fr)
CA (1) CA2857210A1 (fr)
ES (1) ES2670894T3 (fr)
HK (1) HK1199064A1 (fr)
IL (1) IL232848A0 (fr)
IN (1) IN2014CN03882A (fr)
RU (1) RU2014121383A (fr)
SG (1) SG11201402476XA (fr)
TW (3) TW201632625A (fr)
WO (1) WO2013080934A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2565428T3 (es) * 2010-07-07 2016-04-04 Daiichi Sankyo Company, Limited Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
JP2018038333A (ja) * 2016-09-08 2018-03-15 ライフテクノロジーズジャパン株式会社 細胞の作製方法、発現用ベクター及び細胞
KR102553990B1 (ko) * 2016-10-03 2023-07-10 다이이찌 산쿄 가부시키가이샤 Hspa5 유전자의 프로모터
TW202020160A (zh) 2018-08-09 2020-06-01 日商第一三共股份有限公司 Hspa8 基因之啟動子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507087A (ja) * 1995-12-22 2000-06-13 ギスト ブロカデス ベスローテン ファンノートシャップ ファフィア株を形質転換する改良法、そのようにして得られた形質転換したファフィア株及び前記方法における組換えｄｎａ
US20030232056A1 (en) * 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
JP4676639B2 (ja) * 2001-04-17 2011-04-27 月桂冠株式会社 アスペルギルス属由来の新規なプロモーター
ES2665493T3 (es) * 2003-06-24 2018-04-26 Genzyme Corporation Nuevos promotores de la beta-actina y rpS21, y sus usos
GB0509965D0 (en) * 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
AU2008204442B2 (en) * 2007-01-12 2013-03-14 Intrexon Actobiotics Nv Lactococcus promoters and uses thereof
WO2009155950A1 (fr) * 2008-06-27 2009-12-30 King Faisal Specialist Hospital And Research Centre Procédé sans clonage destiné à générer des constructions rapporteurs linéaires actives d'expression régulée au niveau transcriptionnel et post-transcriptionnel
ES2565428T3 (es) * 2010-07-07 2016-04-04 Daiichi Sankyo Company, Limited Elemento de ADN que tiene actividad de aumento de expresión de un gen exógeno
EP2611915B1 (fr) * 2010-09-01 2015-04-15 Cellagenics B.V. Fragments d'acide nucléique provenant d'un promoteur de la protéine ribosomale, destinés à améliorer l'expression génique

Also Published As

Publication number Publication date
TW201632624A (zh) 2016-09-16
BR112014012682A2 (pt) 2019-09-24
IL232848A0 (en) 2014-07-31
US20140342401A1 (en) 2014-11-20
AU2012344855B2 (en) 2018-01-18
KR101931404B1 (ko) 2018-12-20
SG11201402476XA (en) 2015-02-27
TW201329234A (zh) 2013-07-16
EP2787080A1 (fr) 2014-10-08
TW201632625A (zh) 2016-09-16
ES2670894T3 (es) 2018-06-01
RU2014121383A (ru) 2016-01-27
AU2012344855C1 (en) 2018-04-12
WO2013080934A1 (fr) 2013-06-06
JP6025745B2 (ja) 2016-11-16
IN2014CN03882A (fr) 2015-09-04
EP2787080A4 (fr) 2015-08-12
CA2857210A1 (fr) 2013-06-06
US9862969B2 (en) 2018-01-09
AU2012344855A1 (en) 2014-06-19
CN104066839B (zh) 2018-02-16
EP2787080B1 (fr) 2018-03-21
KR20140100475A (ko) 2014-08-14
CN104066839A (zh) 2014-09-24
JPWO2013080934A1 (ja) 2015-04-27

Similar Documents

Publication Publication Date Title
TWI560272B (en) Regulatable promoter
IL231983A0 (en) Dna containing tricyclo-phosphorothioate
GB201118636D0 (en) Nucleotide sequence
AP2014007742A0 (en) Catalysts
AP3757A (en) Catalysts
HK1209048A1 (en) Filaggrin gene expression promoter
IL223642A (en) Inorganic elements to enhance gene expression
GB201410312D0 (en) Photobioreactor
EP2796542A4 (fr) Promoteur de prolifération de bifidobacterium
HK1198507A1 (en) Controls
GB201206455D0 (en) Gene expression
GB2491714B (en) Lining segment
GB201301300D0 (en) No details
EP2529736A4 (fr) Promoteur d'expression pour un facteur associé à une réduction-oxydation
HK1199064A1 (en) Promoter derived from human gene
EP2768941A4 (fr) Photobioréacteur
EP2716258A4 (fr) Segment intrastromal
EP2753627A4 (fr) Catalyse
EP2663657A4 (fr) Assemblage génomique
GB201103407D0 (en) Genetic association
EP2695868A4 (fr) Réfractaire
GB201021720D0 (en) Gene variant
GB201010471D0 (en) Gene variant
GB201117144D0 (en) Polymorphs
GB201121574D0 (en) Transforming genetic sequences